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Abstract 
Bone changes related to diabetes have been well stablished, but few strategies have been developed to prevent 
this growing health problem. In our work we propose to investigate the effects of calcitriol as well as of a 
vitamin D analog (paricalcitol) and a calcimimetic (cinacalcet), in fin regeneration and de novo mineralization 
in a zebrafish model of diabetes. Following exposure of diabetic transgenic Tg(ins:nfsb-mCherry) zebrafish to 
calcitriol, paricalcitol and cinacalcet, caudal fins were amputated to assess their effects on tissue regeneration. 
Caudal fin mineralized and regenerated areas were quantified by in vivo alizarin red staining. Quantitative real 
time PCR was performed using RNA from the vertebral column. Diabetic fish treated with cinacalcet and 
paricalcitol presented increased regenerated and mineralized areas when compared to non-treated diabetic 
group, while no significant increase was observed in non-diabetic fish treated with both drugs. Gene expression 
analysis showed an upregulation for runt-related transcription factor 2b (runx2b), bone gamma-
carboxyglutamic acid-containing protein (bglap), insulin a (insa) and insulin b (insb) and a trend of increase 
for sp7 transcription factor (sp7) in diabetic groups treated with cinacalcet and paricalcitol. Expression of insra 
and vdra was upregulated in both diabetic and non-diabetic fish treated with cinacalcet. In non-diabetic fish 
treated with paricalcitol and cinacalcet a similar increase in gene expression could be observed but not so 
pronounced. The increased mineralization and regeneration in diabetic zebrafish treated with cinacalcet and 
paricalcitol can be explained by increased osteoblastic differentiation and increased insulin expression 
indicating pro-osteogenic potential of both drugs.   
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Introduction 
Prevalence of diabetes mellitus worldwide was estimated to be of 135 million in 1995 and is predicted to be of 
300 million in the year 2025 
1
 leading to an increase in patients living with the risk of developing diabetes-
related complications 
2
. Diabetes has been strongly associated with development of bone fractures, that begins 
in childhood and extends throughout life, leading to morbidity and mortality 
3
. Calcitriol (1,25-
dihydroxyvitamin D3 - VitD) deficiency is common in chronic kidney disease (CKD) patients, leading to 
secondary hyperparathyroidism (SH) 
4
 and particularly in those diabetic patients that also undergo dialysis, 
there is a clear correlation with low 25-hydroxyvitamin D low serum 
5
. Parathyroid hormone (PTH) stimulates 
bone resorption directly by activating PTH receptors in mesenchymal cells of the osteoblast lineage and 
indirectly by increasing differentiation and function of osteoclasts 
6
. Bone loss and increased fracture risk are 
among the complications presented by CKD patients with SH 
7,8
 and are also seen in rodents 
9
. VitD, the 
vitamin D analog paricalcitol 
10
 and the calcimimetic cinacalcet 
11
 have been used for the treatment of SH in 
CKD patients with beneficial effects in lowering PTH values and also in increasing bone mass 
7,8
. Paricalcitol, 
by selectively activating the vitamin D receptor (VDR) 
12,13
, and cinacalcet, by activating the calcium sensing 
receptor(CaSR) 
12,14
 in parathyroid, have been shown to be more efficient and fast in normalizing PTH levels 
and in reducing circulating bone turnover markers than VitD in patients with SH
15,16
.  In addition, VDR and 
CaSR activation have been associated with increased insulin expression 
17,18
 and beneficial effects were 
reported under diabetic conditions 
19,20
.  Nevertheless, little is known on whether upregulation of insulin can 
occur in extrapancreatic tissues.  In humans, extrapancreatic expression of insulin was first identified in brain 
21
 
and then in thymus 
22
, as a way for the immune system to recognize insulin, avoiding autoimmunity and  β-cell 
destruction. Later Kojima et al (2003, 2004) 
23,24
 showed the presence of cells positive for insulin RNA in the 
liver, adipose tissue and bone marrow in several diabetic mice models, but not in nondiabetic mice. However, 
this insulin expressing cells had no impact on reducing hyperglycemia in diabetic mice. Later, Kojima et al. 
25
 
demonstrated that beside not having any impact in regulating glucose levels, this Proins/TNF-α-expressing cells 
had their origin in bone marrow and then migrated to several parts of the body, initiating diabetic neuropathy 
26
. 
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Cunha et al 
27
, in their experiments with diabetic mice treated with streptozotocin, observed beneficial effects in 
the secretion of insulin by the tear film of the eye and showed that insulin was locally synthesized in the 
lachrymal gland 
27
. With the current body of evidence, it is difficult to determine if extrapancreatic expression 
of insulin has any effect in glucose homeostasis, or if it serves other undetermined functions. 
Zebrafish have been well established as a model for human diseases, spanning a wide range of human 
pathologies including genetic disorders and physiological processes that are known to be highly conserved 
throughout vertebrate evolution 
28
. Recently it was demonstrated, under type 1 diabetic conditions, that fin 
regeneration was impaired in zebrafish with reduced cell proliferation and increased cell apoptosis 
29
. We 
conducted experimental trials to understand if VitD, paricalcitol and cinacalcet, could have beneficial effects on 
caudal fin regeneration and bone mineralization in adult zebrafish and in operculum development of larvae 
under type 1 diabetic conditions. To test this hypothesis we used the transgenic Tg(ins:nfsb-mCherry) zebrafish 
that after being exposed to the pro-drug metronidazole becomes hyperglycemic and hipoinsulinemic due to 
beta-cell ablation, leading to a transient state of diabetes of 10 to 15 days prior to beta-cell regeneration 
30,31
. To 
understand if vitamin D analogs and calcimimetics could have positive effects on bone development and 
mineralization, during a transient diabetes type I state, fin regeneration and bone mineralization were assessed 
and expression of bone and vitamin D metabolism markers evaluated. 
 
Methods 
Zebrafish strains and maintenance: The transgenic Tg(ins:nfsb-mCherry) zebrafish line used in our 
experiments was kindly given by the Laboratory of Molecular Biology and Genetic Engineering, GIGA 
Research, Liege, Belgium.  Transgenic zebrafish were maintained in a recirculating water system (Tecniplast, 
Buguggiate, Italy). All manipulations were performed by licensed researchers and conducted in accordance 
with principles and procedures following the guidelines from the Federation of Laboratory Animal Science 
Associations (FELASA) and in accordance with the EU and national regulations. The Tg(ins:nfsb-mCherry) 
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line generated by Pisharat et al. 
30
 with a Tübingen AB background, contains a construct in which the nfsB gene 
of E. coli and the florescent protein mCherry are inserted downstream to the promoter region of the insa gene. 
That bacterial gene encodes a nitroreductase (NTR) enzyme, that converts pro-drugs such as metronidazole 
(MET; Sigma-Aldrich, St. Louis, USA) to cytotoxins. By observation of loss mCherry florescence after MET 
treatment it is possible to visualize MET dependent β-cell ablation. 
Procedures   
Diabetes induction: Larvae at 15 days post fertilization and male and female adults with 1 year old from the 
Tg(ins:nfsb-mCherry) zebrafish line were anesthetized with tricaine methanesulfonate (Sigma-Aldrich, St. 
Louis, USA) 
32
 and exposed to MET either by bath or through intraperitoneal (IP) injection at the concentration 
of 0,05M dissolved in citrate buffer (0,05M). Corresponding control groups were left untreated under the same 
housing conditions. Additionally, we have exposed non-transgenic siblings from a cross between a 
heterozygous transgenic and a wild type zebrafish, to discard potentially side effects of MET treatment in 
caudal fin regeneration. Paricalcitol, cinacalcet and VitD treatments: 72 hours post treatment (hpt) with 
MET, transgenic zebrafish were screened for loss of fluorescence due to β-cell ablation, as observed by 
Pisharath et al. 
30
. To understand if treatments could induce bone alterations in diabetic conditions, 240 larvae 
and 145 adults were divided into experimental groups in triplicates and exposed by immersion (larvae) or IP 
injection (adults) of VitD (0,001µg/ml) (calcitriol, Sigma-Aldrich), paricalcitol (0,001µg/ml) (zemplar®, 
Abbott Laboratories, Illinois, USA) and cinacalcet (0,05µg/ml) (mimpara®, Amgen Europe B.V., Breda, 
Netherlands), mimicking the concentrations used in clinical practice. For the control groups of non-diabetic and 
diabetic fish we used a vehicle solution (citrate buffer 0,05M). Since cinacalcet was found to be lethal to larvae 
at the concentration used for adults, we have performed treatments with dilutions of the initial concentration of 
cinacalcet by 1:10 (0.005 µg/ml), 1:50 (0.001 µg/ml) and 1:100 (0.0005 µg/ml) and included three additional 
groups of diabetic and non-diabetic larvae treated with cinacalcet. Fin amputation: After the IP injections with 
treatments or vehicle, the caudal fins of treated adults (n=8) were amputated two segments below the ray 
bifurcation. Both larvae and adults were maintained under treatment for 120 hours at 28.5ºC and fed twice a 
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day with Artemia nauplii (EG strain, Inve, Belgium). Staining of mineralized tissue: Larvae (n=15) were 
fixed with PFA 4% for 1 hour, washed in PBS and stained in 0.01% alizarin red for 30 min. Adults were 
submitted to live staining in alizarin red (n=8) at a concentration of 0.01% for 15 min prior to observation. 
Adult regenerated caudal fins and larval opercula were photographed under fluorescence (546nm) in a 
stereomicroscope (Leica MZ9.5, Leica, Wetzlar, Germany) for identification of the calcified regions. 
Quantification of operculum mineralized area in larvae: Mineralized area of opercula stained by alizarin red 
were measured using image J software. Results were normalized by dividing operculum area (OA) by total area 
of the head (HA) Quantification of regenerated and mineralized area of adult fin: Regenerated area was 
determined by dividing regenerated area (REG) by stump width (STU) and mineralized area was determined by 
dividing mineralized area (MIN) by mean ray width (MRW) and divided by REG/STU. All quantifications 
were done using image J software. Bone histology and histomorphometry: 3 calcified regenerated fins from 
each of the different groups were transferred to 70% EtOH and processed for dehydration and infiltration on a 
routine overnight processing schedule. Samples were then embedded in paraffin and sections with 6 µm 
prepared in a microtome. Before staining, sections were deparaffinized in xylene and dehydrated in an 
increasing gradient of EtOH. Sections were stained by von Kossa´s as described elsewhere 
33
. To determine fin 
area and thickness, the second, third and fourth hemiray of each fin were measured. Area was assessed by 
measuring total area of both hemirays and thickness was assessed by four longitudinal measurements of each 
hemiray. A detailed time course of the different procedures from metronidazole treatment to amputation and 
data acquisition is shown in supplementary figure 1.   
 Glucose tolerance test: To confirm that ablation of β-cells in Tg(ins:nfsb-mCherry) zebrafish led to an 
increase of glucose blood concentrations, we administrated a solution of glucose at a concentration of 0,1 M or 
vehicle by IP injection, to two groups of adult zebrafish after 72 hpt with MET. Blood glucose was monitored 
at 30, 60, 90, 120, 150 and 180 minutes after IP injection with glucose. The glucose levels were measured in 3 
Tg(ins:nfsb-mCherry) zebrafish treated with MET and with vehicle at each time point. 6 µl of blood were 
collected from the caudal aorta, diluted in 2 µl of 2% heparin and rapidly transferred to a blood glucose meter 
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Glucocard
TM
 MX (Arkray A. Menarini Diagnostics, Florence, Italy). All these procedures were repeated four 
times with 6 to 7 specimens by group. Total RNA isolation: Vertebral columns from 6 adults of each group 
were isolated and pooled in 2 groups (n=3/each) for RNA purification. The samples were placed in 1ml of Isol-
RNA Lysis Reagent (5 PRIME, Hilden, Deutschland) and total RNA was purified according to manufacturer’s 
protocol. RNA quantity and integrity were verified using Experion
TM
 RNA Analysis Kit (BIO-RAD, Hercules, 
CA, USA). Quantitative real‐time polymerase chain reaction (qPCR): Reverse transcription of 1 µg of total 
RNA was performed using Moloney Murine Leukemia Virus Reverse Transcriptase (M-MLV RT) (Life 
Technologies, Carlsbad, CA, USA) according to the manufacturer’s protocol. Semi quantitative qPCR was 
performed using iQ™ SYBR
®
 Green Supermix (Life Technologies), on an CFX96 Touch™ Real-Time PCR 
Detection System (BIO-RAD, Hercules, CA, USA), conducted for 45 cycles of 5 s at 95ºC and 15 s at 60ºC 
each. The primer sequences of elongation factor 1alpha (ef1-alpha), 18S ribosomal rna (18S), runt-related 
transcription factor 2 b (runx2b), bone gamma-carboxyglutamic acid-containing protein (bglap), sp7 
transcriptor factor (sp7), parathyroid hormone receptor a (pthra), vitamin D receptor a (vdra), insulin a (insa), 
insulin b (insb) and insulin receptor a (insra) are listed in supplementary Table 1. All gene expression data 
were normalized against the mean of the gene expression levels of housekeeping genes ef1-alfa and 18S. To 
confirm extrapancreatic expression of insa and insb genes observed by qPCR, a RT-PCR reaction was 
performed and the identity of the amplicons confirmed by sequencing. Gene expression results are the mean of 
two different experiments. Statistical analysis: All statistical analyses were performed using Stata Statistical 
Software and data was evaluated using the one-way ANOVA followed by Bonferroni multiple comparisons test 
with p˂0.05 considered statistically significant. Results are presented as means ± standard deviation of the 
mean (SD). 
Results  
As previously described, Tg(ins:nfsb-mCherry) presented loss of fluorescence in the region of the pancreas 
after 72 hpi with MET, confirming β-cell ablation (supplementary figure 2). To confirm that Tg(ins:nfsb-
mCherry) exposed to MET could lead to a state of onset of diabetes, a glucose tolerance test was performed to 
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measure how well animals are able to break down glucose, or sugar. We found that glucose concentrations in 
the plasma of fish treated with MET were significantly higher than in fish treated with vehicle only, with these 
differences being highly significant at 90, 120 ,150 and 180 minutes after IP injection (Figure 1).  
An analysis of the mineralized area of the operculum (Figure 2.A, B) of larvae from the D group revealed a 
significant reduction when compared to non-diabetic samples. However, the mineralized area of the operculum 
was significantly increased when diabetic larvae were treated with paricalcitol, cinacalcet and VitD compared 
to untreated diabetic larvae. Non-diabetic larvae treated with the three different treatments showed a tendency 
for an increase in mineralization compared to untreated non-diabetic larvae, although not significantly different 
due to individual variability (Figure 2.C).  
Following β-cell ablation and regeneration we have quantified the regenerated and mineralized areas (Figure 
3.A). Diabetic zebrafish adults had a statistically significant impairment of fin regeneration when compared to 
non-diabetics. Furthermore, the diabetic and non-diabetic groups treated with paricalcitol and cinacalcet 
presented a significant increase in regenerated area when compared to diabetic fish, but a not significant 
increase in regeneration when compared to non-diabetics (figure 3.B). In non-diabetic treated groups, the 
increase in regenerated area was not significant. The regenerated area of the diabetic and non-diabetic zebrafish 
groups treated with VitD did not present any significant differences compared to respective control groups 
(Figure 3.B). Wild type (WT) fish treated with MET showed no differences to non-diabetics or to control WT 
fish exposed to vehicle.   
Quantification of the mineralized area showed that groups treated with paricalcitol and cinacalcet had no 
differences when compared to untreated non-diabetic fish while the diabetic fish showed a significantly reduced 
mineralization when compared to non-diabetic and with diabetic paricalcitol and cinacalcet treated groups, 
while VitD treated groups showed no differences relative to the other treated groups (figure 3.C). Non- 
transgenic siblings treated with MET or vehicle (WT, WT+MET) showed no alterations both in regenerated and 
mineralized areas when compared to the ND group (figure 3.B and 3.C). 
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Histology of rays confirmed previous results, showing increased ray area and thickness (figure 4.A) in the 
regenerated caudal fins of diabetic fish treated with paricalcitol and cinacalcet when compared to untreated 
diabetic fish, while non-diabetic treated groups showed no significant increase (figure 4.B and 4.C).   
Analysis of gene expression levels showed no significant differences relative to the expression of pthra when 
comparing non-diabetic and diabetic fish (figure 5.A). The vdra expression, showed a statistically significant 
increase in the cinacalcet treated groups compared to all other groups (figure 5.B). insra expression was found 
to be significantly down regulated in all diabetic groups (p<0,5) compared to non-diabetic, but the diabetic fish 
treated with cinacalcet showed a lower reduction in expression, with statistically higher values compared to 
diabetic, paricalcitol and VitD treated fish, while nondiabetic cinacalcet treated group showed increased 
expression compared to all other groups (figure 5.C). sp7 expression showed a trend of reduction in all diabetic 
fish treated groups compared to non-diabetics, but significant downregulation was only found in diabetic 
compared to non-diabetic groups, no differences being observed among non-diabetic groups (figure 5.D). 
Regarding runx2b, a significant upregulation could be observed in groups treated with paricalcitol and 
cinacalcet (figure 5.E). Expression of bglap was downregulated in diabetic compared to non-diabetic fish while 
the paricalcitol and cinacalcet diabetic groups showed significant differences compared to untreated diabetic 
group. In non-diabetic fish, treated versus control groups were not significantly different. Gene expression of 
insa and insb were found to be upregulated (p<0.001) in both diabetic and non-diabetic paricalcitol and 
cinacalcet treated fish when compared to the other groups (figures 4.G and 4.H). 
To demonstrate the extrapancreatic expression of both insa and insb in vertebral column, we performed an RT-
PCR using cDNA of liver/pancreas, muscle, kidney, column and cleithrum/operculum from wild type zebrafish, 
using the same primers used for qPCR. We observed amplification of ins genes in all tissues analyzed. This 
result was further confirmed by sequencing the PCR amplicons which were confirmed to correspond to insulin 
a and b isoforms respectively (figure 6). 
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Discussion  
This study demonstrated that zebrafish is a suitable model for the study of bone pathologies related to diabetes. 
Ablation of β-cell, by exposing Tg(ins:nfsb-mCherry) zebrafish to MET, led to loss of mCherry fluorescence in 
the β-cells at 72 hpi, as already described by previous authors 
30,31
, and to blood glucose increase, although 
differences were not as accentuated as previously reported  
30,31
. Beta-cell ablation was confirmed by loss of 
mCherry fluorescence after 72 hours of treatment with MET. Transgenic fish that did not present a total loss of 
fluorescence were removed from further experimental procedures. The injection of glucose in diabetic fish led 
to an increase of the plasma glucose levels significantly higher than in non-diabetic controls. The levels of 
blood glucose started to decrease after 120 min post treatment, although they remained significantly higher in 
diabetic fish while in non-diabetics the levels returned to pre-treatment levels. The reduction of glucose levels 
in plasma observed in diabetic fish can be explained by elimination of excess plasma glucose in urine, as 
previously reported for other species, where after injection with levels from 6.4mM to 25mM glucose in tilapia 
the excretion of excess glucose in the urine was visible after few hours. It was reported that treated fish had a 
drastic increase in urine glucose levels that were the double of the values measured in plasma 
34
. It has also 
been shown in rainbow trout that there is a renal regulation of glucose levels in the plasma with the observation 
that high concentrations of glucose in plasma lead to glycosuria and to elimination in the urine 
35
. Moreover, it 
is known that small fish are considered to have lower glucose tolerance than large fish 
36
.  
 Induction of diabetes in zebrafish caused an impairment in operculum mineralization and bone growth in 15 
day larvae, similar to growth retardation observed in diabetes type 1 patients 
37
 and diabetes mice models 
38
. 
Treatment with paricalcitol was more efficient than with VitD in promoting an increase in the mineralized area. 
The concentrations of Cinacalcet in our zebrafish treatments were the same as used in clinical therapies, but 
were found to be toxic in larvae with a rate of mortality of 100% after 24 hours. However, lower concentrations 
showed reduced lethality and induced an increase in mineralized area. Regenerated fin areas of adults showed 
an increase in the diabetic groups treated with paricalcitol and cinacalcet when compared to diabetic group 
treated with vehicle, while diabetic fish treated with VitD did not present such a marked increase. There are 
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some evidences that vitamin D analogs can have positive regenerative effects after vascular injury, as 
previously reported for healthy humans, diabetic mice models and conditional knockout of the vitamin 
D receptor mice 
39
.  
In our work, paricalcitol had no effect in vdra expression, but we could detect an upregulation in the group 
treated with cinacalcet, in agreement with previous in vitro studies with rat parathyroid glands, demonstrating 
that class II calcimimetics induce a stimulatory affect in Vdra expression 
40
.  Additionally, gene expression 
results for both insa and insb, which were found to be overexpressed in bone in diabetics treated with 
paricalcitol or cinacalcet, could help explain this increase in caudal fin regeneration. Vitamin D analogs and 
calcimimetics have been shown to induce insulin expression and β-cell proliferation and survival 
41–43
, and our 
data suggest that this upregulation of insulin also occurs in bone cells. In the Tg(ins:nfsb-mCherry) zebrafish, it 
has been described that total pancreas regeneration occurs in 15 days after diabetes induction, but we do not 
know if this process occurred in a shorter period of time in the paricalcitol and cinacalcet treated groups, which 
could favor insulin signaling and glucose metabolism. In the cinacalcet treated group we could observe a 
significant increase in insr suggesting increased insulin signaling. In fact, VitD may have an important role in 
the treatment of diabetes as identified by Del Pino-Montes et al (2004) 
44
, who showed that 55% of diabetic rats 
treated with calcitriol recovered from diabetes.  
Insulin expression has also been found to be increased in several tissues under diabetic conditions in both 
humans and mice 
45
, but in our study we could not observe such an increase in the non-treated diabetic group, at 
least in the vertebral column. It has been demonstrated that insulin can be almost ubiquitously expressed in 
human 
46
, mice 
45
 and zebrafish 
47
 although at extremely low levels when compared to pancreatic insulin. 
Although not well understood, the function of extrapancreatic expression of insulin was associated in some 
works to local needs of glucose regulation, specially under diabetic conditions 
46,48
, but in other reports this 
phenomenon was related to the development of pathologic conditions 
29
. Our results demonstrated that 
paricalcitol and cinacalcet can upregulate extrapancreatic expression of insulin, including in bony tissues, like 
demonstrated in the vertebral column of adult zebrafish.  
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In humans and animal models of diabetes, hyperglycemia leads to accelerated accumulation of advanced 
glycation end products (AGEs) 
49
, promoting an inflammatory response and increased apoptosis of cells 
expressing the receptor of AGEs such as osteoblasts 
50
. In the non-treated diabetic group we could see 
impairment in osteoblastic activity, since sp7, runx2b and bglap expression were found to be downregulated 
compared to non-diabetic fish. In the diabetic groups treated with paricalcitol or cinacalcet, where an increase 
in mineralized area of the regenerated fin was observed, an upregulation of runx2b suggests an increase in the 
process of osteoblastic differentiation, contributing to the process of mineralization. This is in accordance with 
studies in humans, indicating that VitD effects on osteoblast differentiation are mostly stimulatory and 
associated with increased RUNX2 expression 
51
. Additionally, in vitro studies with mesenchymal stem cells 
from human amniotic fluid have correlated calcimimetics with osteogenic differentiation and upregulation of 
bone markers including RUNX2 
52
.  The principal objective of paricalcitol, cinacalcet and VitD in clinical 
treatment for SH is to reduce parathyroid hormone secretion. We could not observe reduced expression in pthra 
in all treated groups so no conclusions can be made relatively to the pth regulation of osteoclastic 
differentiation and bone resorption 
53
. In fact, pthra results seems to support the idea that pth pathway was not 
altered in the treated groups because the VitD treated group did not present such a marked increase in 
mineralized area as observed in the other two treated groups, while having the same results for pthra. The fact 
that VitD acts more slowly in exerting its effects, at least when compared to paricalcitol 
54
, can be one of the 
possible explanations for our results. Different pathways related to pth signaling, calcium metabolism or VitD 
induced osteoblastogenesis can be involved in the increase in bone mineralized and regenerated areas observed 
in the caudal fin of zebrafish under diabetic conditions treated with paricalcitol and cinacalcet. Upregulation of 
insulin and increased osteoblastic differentiation induced by upregulation of runx2b can help explain our 
results. Both paricalcitol and cinacalcet were shown to have positive effects in promoting mineral deposition, 
counteracting bone loss related to diabetes, and may constitute an alternative therapy for prevention of bone 
related disorders observed in type I diabetes patients.  
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Figure legends 
Figure 1. Transgenic zebrafish Tg(ins:nfsb-mCherry) 72 hours post induction of diabetes have increased blood 
glucose concentrations at 30, 60, 90, 120, 150, 180 min. after intra-peritoneal  injection with glucose *p<0,05; 
**p<0,001. 
Figure 2. A. Measurements of operculum mineralized areas; B. Size of the operculum was obtained by dividing 
the operculum area by total head area; C. 15 day old diabetic larvae have reduced operculum mineralized area 
when compared to non-diabetic, but treatment with paricalcitol and cinacalcet at 0.005 µg/ml, 0.001 µg/ml and 
0.0005 µg/ml were found to increase the mineralized area compared to diabetic larvae. Bars with different 
superscript letters indicate significant differences (p<0.05). Operculum area (OA), total area of the head (HA). 
ND non-diabetic; D diabetic; D CC 1:10, D CC 1:50, D CC 1:100, ND CC 1:10, ND CC 1:50, ND CC 1:100 
diabetic and non-diabetic groups treated with cinacalcet at concentrations 10, 50 and 100 times lower than the 
used in clinical practice; D PCT and ND PCT diabetic and non-diabetic treated with paricalcitol; D VitD and 
ND VitD diabetic and non-diabetic treated with vitamin D. 
Figure 3. A. Measurements of regenerated (top row) and mineralized (bottom row) areas in non-diabetic 
(ND)and diabetic (D) zebrafish adults treated with vitamin D (VitD), paricalcitol (PCT) and cinacalcet (CC) 
and in control wild type AB (WT) zebrafish or treated with metronidazole (MET); B. Diabetic group had 
decreased fin regenerated area compared to non-diabetic and to diabetic treated with paricalcitol and cinacalcet; 
C. Diabetic group had decreased fin mineralized area compared to non-diabetic and to diabetic treated with 
paricalcitol and cinacalcet. Bars with different superscript letters indicate significant differences (p<0.05). 
Regenerated area (REG), stump width (STU), mineralized area (MIN), mean ray width (MRW). 
Figure 4. A. Histological sections of regenerated caudal fin rays stained by von Kossa. B. Diabetic group alone 
or treated with VitD presents reduced ray area compared to all other groups. C. Diabetic group alone presents 
reduced thickness compared to all other groups except diabetic treated with VitD. 
Figure 5. RNA gene expression from the vertebral column of diabetic or diabetic with treatments is altered in 
zebrafish; A. Diabetic and non-diabetic treated groups showed no significant differences in pthra expression; B. 
Diabetic and non-diabetic treated with cinacalcet have an increase in vdra expression compared to all the other 
groups; C. Diabetic and non-diabetic groups treated with cinacalcet showed increased expression of insra; D. 
The diabetic fish showed a downregulation of sp7 compared to non-diabetics. The treated groups showed no 
differences relatively to untreated groups; E. Both diabetic and non-diabetic groups treated with paricalcitol and 
cinacalcet showed an increase in the expression of runx2b; F. Diabetic group showed reduced expression of 
bglap compared to non-diabetic fish. All the treated groups with paricalcitol and cinacalcet showed significant 
Page 18 of 26
Wound Repair and Regeneration
Manuscript under review - CONFIDENTIAL
This article is protected by copyright. All rights reserved.
upregulation relatively to the untreated diabetic group; G. and H. Diabetic and non-diabetic groups treated with 
paricalcitol and cinacalcet showed an increase in the expression of both insa and insb gene. Bars with different 
superscript letters indicate significant differences (p<0.05). 
Figure 6. Zebrafish presented extrapancreatic expression of both insa and insb. Expression of insa and insb 
could be detected in pancreas/liver, muscle, kidney, and bones from vertebral column and cleithrum/operculum.  
 
Supplementary figure legends 
Supplementary Figure 1.  Detailed timeline of diabetes induction and treatment with experimental drugs 
during caudal fin regeneration. 
Supplementary Figure 2. Confirmation of beta-cell ablation. A. Metronidazole exposed Tg(ins:nsfb-mCherry) 
zebrafish lose mCherry fluorescence after 72 hours of treatment. B. Vehicle exposed Tg(ins:nsfb-mCherry) 
zebrafish maintain mCherry fluorescence after treatment. 
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Figure 1. Transgenic zebrafish Tg(ins:nfsb-mcherry) 72 hours post induction of diabetes have increased 
blood glucose concentrations at 30, 60, 90, 120, 150, 180 min. after intra-peritoneal  injection with glucose 
*p<0,05; **p<0,001.  
Figure 1  
100x71mm (300 x 300 DPI)  
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Figure 2. A. Measurements of operculum mineralized areas; B. Size of the operculum was obtained by 
dividing the operculum area by total head area; C. 15 day old diabetic larvae have reduced operculum 
mineralized area when compared to non-diabetic, but treatment with paricalcitol and cinacalcet at 0,005 
µg/ml, 0,001 µg/ml and 0,0005 µg/ml were found to increase the mineralized area compared to diabetic 
larvae. Bars with different superscript letters indicate significant differences (p<0,05). Operculum area (OA), 
total area of the head (HA). ND non-diabetic; D diabetic; D CC 1:10, D CC 1:50, D CC 1:100, ND CC 1:10, 
ND CC 1:50, ND CC 1:100 diabetic and non-diabetic groups treated with cinacalcet at concentrations 10, 50, 
100 smaller than the used in clinical practice; D PCT and ND PCT diabetic and non-diabetic treated with 
paricalcitol; D VitD and ND VitD diabetic and non-diabetic treated with vitamin D.  
Figure 2  
176x116mm (300 x 300 DPI)  
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Figure 3. A. Measurements of regenerated (top row) and mineralized (bottom row) areas in non-diabetic 
(ND)and diabetic (D) zebrafish adults treated with vitamin D (VitD), paricalcitol (PCT) and cinacalcet (CC) 
and in control wild type AB (WT) zebrafish or treated with metronidazole (MET); B. Diabetic group had 
decreased fin regenerated area compared to non-diabetic and to diabetic treated with paricalcitol and 
cinacalcet; C. Diabetic group had decreased fin mineralized area compared to non-diabetic and to diabetic 
treated with paricalcitol and cinacalcet. Bars with different superscript letters indicate significant differences 
(p<0.05). Regenerated area (REG), stump width (STU), mineralized area (MIN), mean ray width (MRW).  
Figure 3  
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Figure 4. A. Histological sections of regenerated caudal fin rays stained by von Kossa. B. Diabetic group 
alone or treated with VitD presents reduced ray area compared to all other groups. C. Diabetic group alone 
presents reduced thickness compared to all other groups except diabetic treated with VitD.  
Figure 4  
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Figure 5. RNA gene expression from the vertebral column of diabetic or diabetic with treatments is altered in 
zebrafish; A. Diabetic and non-diabetic treated groups showed no significant differences in pthra expression; 
B. Diabetic and non-diabetic treated with cinacalcet have an increase in vdra expression compared to all the 
other groups; C. Diabetic and non-diabetic groups treated with cinacalcet showed increased expression of 
insra; D. The diabetic fish showed a downregulation of sp7 compared to non-diabetics. The treated groups 
showed no differences relatively to untreated groups ; E. Both diabetic and non-diabetic groups treated with 
paricalcitol and cinacalcet showed an increase in the expression of runx2b; F. Diabetic group showed 
reduced expression of bglap compared to non-diabetic fish. All the treated groups with paricalcitol and 
cinacalcet showed significant upregulation relatively to the untreated diabetic group; G. and H. Diabetic and 
non-diabetic groups treated with paricalcitol and cinacalcet showed an increase in the expression of both 
insa and insb gene. Bars with different superscript letters indicate significant differences (p<0,05).  
Figure 5  
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Figure 6. Zebrafish presented extrapancreatic expression of both insa and insb. Expression of insa and insb 
could be detected in pancreas/liver, muscle, kidney, and bones from vertebral column and 
cleithrum/operculum.  
Figure 6  
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 Table 1- List of primers. Sequences presented in 5´to 3´orientation. 
ef1a Forward AGCCCCTCCTGGCTTTCACCC 
ef1a Reverse TGGGACGAAGGCAACACTGGC 
18s Forward ACCACCCACAGAATCGAGAAA 
18s Reverse GCCTGCGGCTTAATTTGACT 
runx2 Forward GCACGGAGAGGGACTGACGG 
runx2 Reverse AGGGCCACCACCTTAAACGC 
oc Forward CCAACTCCGCATCAGACTCCGCATCA 
oc Reverse AGCAACACTCCGCTTCAGCAGCACAT 
osx Forward GTTTCCCAGGACCCTTCGCT 
osx Reverse GCAATCGCAAGAAGACCTCC 
pth1ra Forward GTTTCGTCTATGGTCTGGTCG 
pth1ra Reverse GATTGCTCGCTCACATTTTC 
vdr Forward GTCCAACCAGTCCTTCAGTCT 
vdr Reverse AGTGTGACCCGCCTTAGTG 
insb Forward CTCTGCTCACTCAGGAAAAGG 
insb Reverse GGATGGAGAAGACTGCGAT 
insa Forward CATTCCTCGCCTCTGCTTC 
insa Reverse TGCCTGGGTTAGTGCTTACA 
insra Forward TCTACAGCGAGGAAAACAAGC 
insra Reverse AGAGATAAGATGCGTCCGTTTT 
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